UM
(Note: the search results are based on claimed items)

Browse/Search Results:  1-10 of 17 Help

Filters                        
Selected(0)Clear Items/Page:    Sort:
Deciphering the Pharmacological Mechanisms of the Huayu-Qiangshen-Tongbi Formula Through Integrating Network Pharmacology and In Vitro Pharmacological Investigation Journal article
FRONTIERS IN PHARMACOLOGY, 2019,Volume: 10
Authors:  Zihao Wang;  Ke-Gang Linghu;  Yuanjia Hu;  Huali Zuo;  Hao Yi;  Shi-Hang Xiong;  Jinjian Lu;  Ging Chan;  Hua Yu;  Run-Yue Huang
Favorite  |  View/Download:9/0  |  Submit date:2019/12/04
Rheumatoid Arthritis  Network Pharmacology  Traditional Chinese Medicine  Huayu-qiangshen-tongbi Formula  In Vitro Validation  
Research and development of anti-Alzheimer's disease drugs: an update from the perspective of technology flows Journal article
EXPERT OPINION ON THERAPEUTIC PATENTS, 2018,Volume: 28,Issue: 4,Page: 341-350
Authors:  Liu, Kunmeng;  Lin, Hui-Heng;  Pi, Rongbiao;  Mak, Shinghung;  Han, Yifan;  Hu, Yuanjia
Favorite  |  View/Download:2/0  |  Submit date:2018/10/31
Alzheimer's disease  patent  technology flow  citation network  research and development  
Global patent landscape of programmed cell death 1: implications of the rapid expansion Journal article
EXPERT OPINION ON THERAPEUTIC PATENTS, 2018,Volume: 28,Issue: 1,Page: 69-80
Authors:  Kong, Xiangjun;  Zhang, Qianru;  Lai, Yunfeng;  Hu, Hao;  Chen, Xin;  Hu, Yuanjia
Favorite  |  View/Download:23/0  |  Submit date:2018/10/30
Programmed Cell Death 1 (Pd-1)  Patent Landscape  Patent Citation Network  Co-patent  Technology Flow  Immunotherapy  
Progress of Studies on Traditional Chinese Medicine Based on Complex Network Analysis Journal article
Wordl Journal of Traditional Chinese Medicine, 2017,Volume: 3,Issue: 3,Page: 28-37
Authors:  Qian‑Ru Zhang;  Xiang‑Jun Kong;  Hai‑Yu Xu;  Yi‑Tao Wang;  Yuan‑Jia Hu
Favorite  |  View/Download:1/0  |  Submit date:2019/01/10
Complex Network Analysis  Formula  Mechanism  Syndrome  Traditional Chinese Medicine  
Obstacles and opportunities in Chinese pharmaceutical innovation Journal article
Globalization and Health, 2017,Volume: 13,Issue: 1,Page: 21
Authors:  Ni J.;  Zhao J.;  Ung C.O.L.;  Hu Y.;  Hu H.;  Wang Y.
Favorite  |  View/Download:13/0  |  Submit date:2018/11/06
China  Global Network  Innovation  Obstacles  Opportunities  Pharmaceutical Industry  
Pharmaceutical innovation network: Global patterns and the role of China Book chapter
出自: Innovation Value Chain of Chinese Pharmaceuticals, Whitestone, New York:United States-China Intellectual Property Institute Inc., 2017, 页码: 259-281
Authors:  Pengpeng Li;  Huiheng Lin;  Yuanjia Hu
Favorite  |  View/Download:14/0  |  Submit date:2019/01/15
Pharmaceutical Innovation  Drug Patents  Network Analysis  
Innovation Value Chain of Chinese Pharmaceuticals Book
141-07 20th Avenue World Plaza, Suite 604 Whitestone, NY 11357:United States-China Intellectual Property Institute Inc., 2017
Authors:  Yitao Wang;  Yuanjia Hu;  Albert Wai-Kit Chan
Favorite  |  View/Download:18/0  |  Submit date:2019/01/14
China  Pharmaceutical Industry  Obstacles  Opportunities  Global Network  Innovation  
Collaboration networks for R&D of monoclonal antibodies: An analysis based on pipeline projects Book chapter
出自: Innovation Value Chain of Chinese Pharmaceuticals, Whitestone, New York:United States-China Intellectual Property Institute Inc., 2017, 页码: 135-158
Authors:  Tianhong Yin;  Xiangjun Kong;  Yitao Wang;  Xin Chen;  Yuanjia Hu;  Rong Shao
Favorite  |  View/Download:15/0  |  Submit date:2019/01/14
Monoclonal Antibodies  Research And Development  Network Analysis  Institutional Collaboration Network  Country-based Collaboration Network  
Evolving patterns in a collaboration network of global R&D on monoclonal antibodies Journal article
MABS, 2017,Volume: 9,Issue: 7,Page: 1041-1051
Authors:  Kong, Xiangjun;  Wan, Jian-bo;  Hu, Hao;  Su, Shibing;  Hu, Yuanjia
Favorite  |  View/Download:13/0  |  Submit date:2018/10/30
Collaboration Network  Dedicated Biotechnology Firms  Inter-organizational Relationship  Mergers And Acquisitions  Monoclonal Antibodies  Network Evolution  r&d  Pharmaceutical Companies  Technological Innovation  
Analyzing the Chinese landscape in anti-diabetic drug research: Leading knowledge production institutions and thematic communities Journal article
Chinese Medicine (United Kingdom), 2016,Volume: 11,Issue: 1
Authors:  Deng J.;  Sitou K.;  Zhang Y.;  Yan R.;  Hu Y.
Favorite  |  View/Download:6/0  |  Submit date:2018/12/28
Anti-diabetes Drug  Chinese Medicines  Greater China  Network Analysis  Research Collaboration Networks